|
RTN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.461460E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.395900E-03 |
| Normal-vs-Stage2 |
2.97049999997689E-06 |
| Normal-vs-Stage3 |
2.176300E-02 |
| Normal-vs-Stage4 |
9.140100E-03 |
| Stage1-vs-Stage2 |
9.243600E-04 |
| Stage1-vs-Stage3 |
3.124400E-01 |
| Stage1-vs-Stage4 |
9.715600E-01 |
| Stage2-vs-Stage3 |
9.372600E-04 |
| Stage2-vs-Stage4 |
1.087900E-02 |
| Stage3-vs-Stage4 |
5.350400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.457500E-03 |
| Normal-vs-AfricanAmerican |
2.609700E-02 |
| Normal-vs-Asian |
2.938500E-03 |
| Caucasian-vs-AfricanAmerican |
9.593000E-01 |
| Caucasian-vs-Asian |
4.703800E-01 |
| AfricanAmerican-vs-Asian |
6.618000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.135500E-03 |
| Normal-vs-Female |
1.779300E-03 |
| Male-vs-Female |
8.021800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.220400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.042440E-03 |
| Normal-vs-Age(61-80Yrs) |
2.236300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.069400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.149240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.708400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.474400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.485800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.826800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.475000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.332500E-02 |
| Classical-VS-Follicular |
7.38931138499765E-12 |
| Classical-VS-Other |
8.588600E-01 |
| Classical-VS-Normal |
2.222100E-02 |
| Tall-VS-Follicular |
1.52419999954745E-08 |
| Tall-VS-Other |
2.646600E-01 |
| Tall-VS-Normal |
6.523800E-01 |
| Follicular-VS-Other |
4.263800E-02 |
| Follicular-VS-Normal |
6.10999999484108E-08 |
| Other-VS-Normal |
3.076400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91579999999836E-05 |
| Normal-vs-N1 |
1.803340E-03 |
| N0-vs-N1 |
1.726390E-01 |
|
|
